Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The condition known as Type 2 Diabetes (T2D) involves persistent inflammation and imbalances in the gut microbiome; however, the potential benefits of using targeted probiotics as a treatment have not been thoroughly investigated (1).
It is a randomized, double-blind, placebo-controlled clinical trial studying 2 x 18 billion CFU/day Bacillus subtilis DE111 + Bifidobacterium bifidum + Bifidobacterium longum + Lacticaseibacillus paracasei + Lactiplantibacillus plantarum TBC0036 + Leuconostoc mesenteroides TBC0037 + Limosilactobacillus reuteri + Pediococcus acidilactici in 57 evaluated patients withType 2 diabetes (T2D) (1)
###…